Duchenne muscular dystrophy
Top Cited Papers
- 18 February 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Reviews Disease Primers
- Vol. 7 (1), 1-19
- https://doi.org/10.1038/s41572-021-00248-3
Abstract
Duchenne muscular dystrophy is a severe, progressive, muscle-wasting disease that leads to difficulties with movement and, eventually, to the need for assisted ventilation and premature death. The disease is caused by mutations in DMD (encoding dystrophin) that abolish the production of dystrophin in muscle. Muscles without dystrophin are more sensitive to damage, resulting in progressive loss of muscle tissue and function, in addition to cardiomyopathy. Recent studies have greatly deepened our understanding of the primary and secondary pathogenetic mechanisms. Guidelines for the multidisciplinary care for Duchenne muscular dystrophy that address obtaining a genetic diagnosis and managing the various aspects of the disease have been established. In addition, a number of therapies that aim to restore the missing dystrophin protein or address secondary pathology have received regulatory approval and many others are in clinical development.Keywords
This publication has 221 references indexed in Scilit:
- VBP15, a novel anti‐inflammatory and membrane‐stabilizer, improves muscular dystrophy without side effectsEMBO Molecular Medicine, 2013
- Autophagy as a new therapeutic target in Duchenne muscular dystrophyCell Death & Disease, 2012
- Nitrosative stress elicited by nNOSµ delocalization inhibits muscle force in dystrophin‐null miceThe Journal of Pathology, 2010
- The Roles of the Dystrophin-Associated Glycoprotein Complex at the SynapseMolecular Neurobiology, 2009
- Immune‐Mediated Mechanisms Potentially Regulate the Disease Time‐Course of Duchenne Muscular Dystrophy and Provide Targets for Therapeutic InterventionPM&R, 2009
- Hypernitrosylated ryanodine receptor calcium release channels are leaky in dystrophic muscleNature Medicine, 2009
- Dystrophin glycoprotein complex‐associated Gβγ subunits activate phosphatidylinositol‐3‐kinase/Akt signaling in skeletal muscle in a laminin‐dependent mannerJournal of Cellular Physiology, 2008
- Genetic and pharmacologic inhibition of mitochondrial-dependent necrosis attenuates muscular dystrophyNature Medicine, 2008
- Deregulated Protein Kinase A Signaling and Myospryn Expression in Muscular DystrophyOnline Journal of Public Health Informatics, 2008
- Plectin 1f scaffolding at the sarcolemma of dystrophic (mdx) muscle fibers through multiple interactions with β-dystroglycanThe Journal of cell biology, 2007